Lab Supply Companies Have Been Selling Antibodies Using Manipulated Images (arstechnica.com) 1
An anonymous reader quotes a report from Ars Technica: Antibodies play a central role in your body's immune defense. But they're also nearly ubiquitous in biological research, being essential for several widely used lab techniques. While some researchers need to go through the process of producing their own antibodies, antibodies to many key proteins are commercially available and can be ordered for overnight delivery. In May, however, Reese Richardson, a post-doc at Northwestern University, discovered that some of the images used to demonstrate how these antibodies performed in lab experiments had been subject to image manipulation -- the sorts of changes that would get a paper retracted if they had appeared in the academic literature. The manipulations ranged from removing background noise to copying and pasting data to fabricate results. Now, he has done a more exhaustive search and found problematic manipulations in images used to market over 17,000 commercial antibodies.
[...] The consequences of this discovery are pretty significant. If you buy an antibody believing it will generate clean, clear data and find it doesn't, many researchers will assume the problem is them. That often leads them to spend time troubleshooting the procedure and trying slightly different conditions to get useful data. If the antibody can't produce those results, all the troubleshooting will have been a waste of time and money. Nature's coverage of the new findings includes quotes from several companies that sell these antibodies that, paraphrased, range from "we'll look into it" to "we don't think it's a problem." Researchers who have spent time frustrated while failing to get an antibody-based experiment to work may think otherwise.
[...] The consequences of this discovery are pretty significant. If you buy an antibody believing it will generate clean, clear data and find it doesn't, many researchers will assume the problem is them. That often leads them to spend time troubleshooting the procedure and trying slightly different conditions to get useful data. If the antibody can't produce those results, all the troubleshooting will have been a waste of time and money. Nature's coverage of the new findings includes quotes from several companies that sell these antibodies that, paraphrased, range from "we'll look into it" to "we don't think it's a problem." Researchers who have spent time frustrated while failing to get an antibody-based experiment to work may think otherwise.